Anzeige
Mehr »
Montag, 08.09.2025 - Börsentäglich über 12.000 News
Tokenisierung entfesselt: Republic führt die Ethereum-Revolution
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A404YL | ISIN: US00773U2078 | Ticker-Symbol: AVU0
Frankfurt
08.09.25 | 08:03
2,940 Euro
-2,65 % -0,080
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ADVERUM BIOTECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
ADVERUM BIOTECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,9403,06022:40

Aktuelle News zur ADVERUM BIOTECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrAdverum Biotechnologies, Inc.: Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)86REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement...
► Artikel lesen
12.08.Adverum Biotechnologies GAAP EPS of -$2.34 misses by $0.098
12.08.Adverum Biotechnologies, Inc. - 10-Q, Quarterly Report3
12.08.Adverum Biotechnologies, Inc. - 8-K, Current Report3
25.06.Adverum Biotechnologies price target lowered to $12 at Mizuho12
20.06.Adverum Biotechnologies, Inc. - S-8, Securities to be offered to employees in employee benefit plans2
ADVERUM BIOTECHNOLOGIES Aktie jetzt für 0€ handeln
18.06.Adverum Biotechnologies, Inc. - 8-K, Current Report1
05.06.Adverum Biotechnologies, Inc.: Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)111REDWOOD CITY, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement...
► Artikel lesen
15.05.Adverum Biotechnologies GAAP EPS of -$2.25 misses by $0.311
14.05.Adverum Biotechnologies, Inc. - 10-Q, Quarterly Report1
14.05.Adverum Biotechnologies, Inc. - 8-K, Current Report3
02.05.Adverum Biotechnologies, Inc.: Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)159REDWOOD CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement...
► Artikel lesen
24.04.Hedge Fund and Insider Trading News: Ken Griffin, Steve Cohen, Scott Bessent, Balyasny Asset Management, Bridgewater Associates, Starboard Value, Maverick Capital, Kodai Capital Management, Antara Capital, Adverum Biotechnologies Inc (ADVM), and More2
16.04.RBC cuts Adverum stock price target to $5 from $103
15.04.Adverum Biotechnologies GAAP EPS of -$1.96 misses by $0.601
15.04.Adverum Biotechnologies, Inc. - 8-K, Current Report1
15.04.Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones161REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in highly...
► Artikel lesen
15.04.Adverum Biotechnologies, Inc. - 10-K, Annual Report1
04.04.Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)167REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted an inducement...
► Artikel lesen
31.03.Adverum Biotechnologies, Inc. - 8-K, Current Report2
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1